EA
ACLS icon

Evolution Advisers’s Axcelis ACLS Stock Holding History

Evolution Advisers’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$0 Buy
+5
New +$742 ﹤0.01% 214

Other funds holding ACLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Evolution Advisers's ACLS Position: Q2 2026 in Review

Evolution Advisers opened a new position in Axcelis (ACLS) in Q2 2026: 5 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #214 among its holdings.

439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Evolution Advisers held 5 shares of Axcelis worth $0 as of Q2 2026.
  • Axcelis was a new Evolution Advisers position in Q2 2026.
  • Axcelis made up ﹤0.01% of Evolution Advisers's portfolio in Q2 2026, its #214 holding.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Evolution Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.